Analysis for LHX
- 📈 Growth — 15/30
- 💰 Profitability — 16/20
- 🏦 Financial Health — 16/20
- 💵 Valuation — 12/20
- ⚠️ Risk — 7/10
Summary:
📈 Growth & Financial Trajectory
Across the six quarters shown, Revenues rise from about $5.34B (Q3 2023) to $21.87B (Q4 2026), signaling strong top-line growth, especially with a sharp Q4 2026 uptick. Net income fluctuates: about $383M to $300M over the span, peaking at $462M in Q3 2026, reflecting earnings volatility amid expanding revenue.
💰 Margins & Cash Flow
Gross margin runs in the mid-20s (roughly 25-27%); operating margin sits around 10-11% on most quarters. Net cash flow from operating activities is positive in each period, with notable strength in late 2026 (Q3 cash flow ~ $640M; Q4 ~ $1.96B). Cash flows from investing and financing are more negative in some periods, but overall liquidity remains sound.
🛡️ Balance Sheet & Liquidity
Total assets around $41-42B; equity near $19-19.5B. Current assets versus current liabilities are near parity (e.g., late 2026: current assets ~$7.6B, current liabilities ~$7.2B). Liabilities are sizeable but balanced with asset base, supporting ongoing liquidity.
⚠️ Key Drivers & Risks
- Drivers: Defense program execution and milestone-driven revenue.
- Risks: Revenue concentration on large programs and defense-budget sensitivity; the Q4 2026 spike may reflect a one-off rather than steady run-rate.